S'abonner

P28 - Over The Counter (OTC) Use and Reasons Of Self-Medication Among Pregnant And Post-Partum Women In Southern Of Morocco - 10/05/24

Doi : 10.1016/j.jeph.2024.202468 
A. Bouqoufi 1, , L. Lahlou 1, F. Ait El Hadj 1, S. Boujraf 2, M. Abdessadek 3, Y. Khabbal 1
1 Laboratory of innovation research in health sciences, therapeutic innovation, Translational research and epidemiology. Faculty of Medicine and Pharmacy Ibn Zohr University, Morocco, Laboratoire de recherche et d'innovation en science de santé, Agadir, Morocco 
2 Clinical Neurosciences Laboratory, Faculty of Medicine, Sidi Mohamed Ben Abdellah University, Fez, Morocco, Fes, Morocco 
3 Laayoune Higher School of Technology, Ibn Zohr University, Laayoune, Morocco, Laayoune, Morocco 

Auteur correspondant

Résumé

Background

Self-medication among pregnant women poses a major risk to the mother and child's health. It's a global concern that requires attention from professional health care. Data on self-medication practice and predictors among pregnant and postpartum women is limited in Morocco, so the aim of this study was to assess the prevalence of self-medication and contributing factors, among pregnant and postpartum women attending the antenatal care of the regional hospital center of Sous Massa region.

Methods

A cross-sectional study was conducted among 420 pregnant and postpartum women who were attending the service of gynecology and obstetrics at the regional hospital center of Sous Massa region from April 2022 to December 2022. The inclusion criteria were all voluntary and consenting pregnant or post-partum women presented themselves for prenatal consultation and women admitted for childbirth at the maternity at regional hospital center Hassan 2. The questionnaire was prepared and reviewed by a panel of specialists in the fields of clinical pharmacology and biostatistics. For content validity, a primary survey was used to conduct a pilot study. An informed consent was distributed to all participants, and those who signed the informed consent were provided with a hard copy of the questionnaires and were given time to complete them. The study protocol was approved by the ethics committee for biomedical research at the Faculty of Medicine and Pharmacy of Rabat, Morocco. Before commencement, the study was approved by the biomedical research ethics committee at Mohamed V University (68-21). Descriptive statistical analyses were performed for the study participants. The logistic regression analysis was used to determine the significance of the association between the outcome and independent variables. P-value <0.05 was considered statistically significant in multivariate analysis. All statistical analyses were performed using Jamovi Software.

Results

A total of 420 pregnant and postpartum women were included in the study. The mean age of the participants was 28.7 (±6.35) years. Of the total, 24.8% practiced self-medication during the current pregnancy with CI 95% (20.9%-29.1%). In this survey, 47.1% of the participants self-medicated in the first trimester, and 23.4% of the participants reported practicing selfmedication in the third trimester. 8.2% of pregnant women use selfmedication at any time in their pregnancies. The therapeutic families concerned with self-medication practice were Analgesics (41.4%), Antacids (20.3%), Antimicrosis (13.5%), and Vitamins (9%). The leading common causes/symptoms which necessitate self-medication among pregnant and postpartum women were Anemia (84.8%), epi gastralgia (16.8%), vomiting, and pyrosis (15.2%). Urinary, Vaginal infections 58 (15%). The main reasons mentioned by the participants for self-medication were the Need for fast release (51.7%), followed by previous experiences with the same drugs (31.7%), and out of 20% of the participants reported difficulties in accessing Healthcare professionals.

Conclusion

The findings of the present study give us knowledge and the state of self-medication among pregnant and postpartum women attending the regional hospital center of Sous Massa. It is recommended that healthcare professionals increase their awareness of pregnant women and implemented suitable strategies to regulate the commercialization, delivery, and use of conventional medications without prescriptions.

Le texte complet de cet article est disponible en PDF.

Keywords : Pregnancy, Therapeutic use, OTC medication, Maternal and Child Health



© 2024  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 72 - N° S2

Article 202468- mai 2024 Retour au numéro
Article précédent Article précédent
  • P27 - Eruptions eczématiformes chroniques du sujet âgé et imputabilité médicamenteuse : l'apport de la standardisation indirecte à partir des données du Système national des données de santé (SNDS)
  • C. Thill, O. Guerin, E. Lacroix, J. Grosjean, P. Joly, F. Tetart, J. Benichou
| Article suivant Article suivant
  • P30 - Structuration automatique des données des dossiers médicaux et exploration statistique interactive
  • S. Contu, R. Schiappa, D. Culié, E. Seutin, T. Pace-Loscos, E. Chamorey

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.